Home > Quotes > ABLX

Ablynx NV American Depositary Shares Quote & Summary Data

Get ABLX Alerts
*Delayed - data as of Dec. 13, 2017  -  Find a broker to begin trading ABLX now
Industry: Health Care
Community Rating:
View:    ABLX Pre-Market
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Intraday Chart

Shares Traded

Trading Range

The current last sale of $23.97 is 35.04% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 24.17 $ 24.25
 Low: $ 23.90 $ 17.75

Company Description (as filed with the SEC)

We are a late-stage clinical biopharmaceutical company utilizing our proprietary Nanobody platform to develop treatments for a broad range of therapeutic indications with an unmet medical need. We believe that Nanobodies represent a leading next generation protein therapeutic technology. We have more than 45 proprietary and partnered Nanobody programs across a range of therapeutic indications including: hematology, inflammation, infectious disease, autoimmune disease, oncology and immuno-oncology. We employ a hybrid business model whereby we pursue our wholly owned programs through to commercialization or key value inflection points while also working with pharmaceutical partners on programs in areas where they bring specific disease expertise and resources.  ... More ...  

Nasdaq Official Price

Research Brokers before you trade

Want to trade FX?

Analyst Info